162 related articles for article (PubMed ID: 8603403)
1. Second malignant neoplasms among long-term survivors of ovarian cancer.
Travis LB; Curtis RE; Boice JD; Platz CE; Hankey BF; Fraumeni JF
Cancer Res; 1996 Apr; 56(7):1564-70. PubMed ID: 8603403
[TBL] [Abstract][Full Text] [Related]
2. Second primary ovarian cancer among women diagnosed previously with cancer.
Hall HI; Jamison P; Weir HK
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
5. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
8. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
[TBL] [Abstract][Full Text] [Related]
9. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
11. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
12. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland cancer in the United States.
Sun EC; Curtis R; Melbye M; Goedert JJ
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
[TBL] [Abstract][Full Text] [Related]
14. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
15. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
16. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.
Ahmed F; Goodman MT; Kosary C; Ruiz B; Wu XC; Chen VW; Correa CN
Cancer; 2006 Sep; 107(5 Suppl):1162-71. PubMed ID: 16838312
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Second cancer following cancer of the breast in Connecticut, 1935-82.
Harvey EB; Brinton LA
Natl Cancer Inst Monogr; 1985 Dec; 68():99-112. PubMed ID: 4088315
[TBL] [Abstract][Full Text] [Related]
19. Second cancer following cancer of the digestive system in Connecticut, 1935-82.
Hoar SK; Wilson J; Blot WJ; McLaughlin JK; Winn DM; Kantor AF
Natl Cancer Inst Monogr; 1985 Dec; 68():49-82. PubMed ID: 4088313
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
